跳至主要内容
临床试验/JPRN-UMIN000005543
JPRN-UMIN000005543已完成未知

The double blind study of the clinical effects of anti-cholinergic agent "imidafenadcin" for COPD patients. - The effects of imidafenacin for COPD.

Graduate School of Medical and Dental Sciences Kagoshima University Pulmonary Medicine0 个研究点目标入组 10 人开始时间: 2011年5月9日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded from participation if they corresponds to a contraindicated matter of imidafenacin(urinary retention, bowel obstruction, paralytic ileus, glaucoma, myasthenica gravis). The patient who is complicated with chronic respiratory desease except COPD. Patient having allergy to anticholinergic agent. The patient who has difficulty perform of the spirometry. In addition, the patient who judged that the examination medical attendant was inappropriate.

研究者

发起方
Graduate School of Medical and Dental Sciences Kagoshima University Pulmonary Medicine

相似试验